These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4019326)

  • 1. Microbial conversion of epsilon-pyrromycinone to 1-hydroxy-11-deoxycarminomycin II.
    Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
    J Antibiot (Tokyo); 1985 Jun; 38(6):821-2. PubMed ID: 4019326
    [No Abstract]   [Full Text] [Related]  

  • 2. Microbial conversion of epsilon-pyrromycinone and epsilon-isorhodomycinone to 1-hydroxy-13-dihydrodaunomcyin and N-formyl-1-hydroxy-13-dihydrodaunomycin and their bioactivities.
    Yoshimoto A; Matsuzawa Y; Oki T; Naganawa H; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1980 Oct; 33(10):1150-7. PubMed ID: 7451366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of 2'-deoxy-L-fucopyranosylcarminomycinone and -epsilon-pyrromycinone as well as 2'-deoxy-D-erythro-pentopyranosyldaunomycinone, -carminomycinone, and -epsilon-pyrromycinone.
    El Khadem HS; Swartz DL
    J Med Chem; 1981 Jan; 24(1):112-5. PubMed ID: 7205866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbial conversion of anthracycline antibiotics. IV. Study on the glycosidation of epsilon-pyrromycinone by Streptomyces galilaeus OBB-111-848.
    Hoshino T; Fujiwara A
    J Antibiot (Tokyo); 1984 Nov; 37(11):1473-4. PubMed ID: 6511669
    [No Abstract]   [Full Text] [Related]  

  • 5. Microbial transformations of natural antitumor agents. 13. Conversions of 13-blocked anthracyclinones.
    Wu GS; Gard A; Rosazza JP
    J Antibiot (Tokyo); 1980 Jul; 33(7):705-10. PubMed ID: 7190964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microbial conversion of steffimycin and steffimycin B to 10-dihydrosteffimycin and 10-dihydrosteffimycin B.
    Wiley PF; Elrod DW; Slavicek JM; Marshall VP
    J Antibiot (Tokyo); 1980 Aug; 33(8):819-23. PubMed ID: 7429984
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbial conversion of anthracyclinones to carminomycins by a blocked mutant of Actinomadura roseoviolacea.
    Nakagawa M; Hayakawa Y; Imamura K; Seto H; Otake N
    J Antibiot (Tokyo); 1989 Nov; 42(11):1698-703. PubMed ID: 2584152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4-O-(beta-D-Glucopyranosyl)-epsilon-rhodomycinone, a new microbial transformation product of rhodomycinone.
    Nakagawa M; Kawai H; Hayakawa Y; Seto H; Otake N
    J Antibiot (Tokyo); 1985 Nov; 38(11):1622-4. PubMed ID: 4077740
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of new anthracycline antibiotics 1-hydroxy-oxaunomycin and 6-deoxyoxaunomycin by limited biosynthetic conversion using a daunorubicin-negative mutant.
    Yoshimoto A; Johdo O; Tone H; Okamoto R; Naganawa H; Sawa T; Takeuchi T
    J Antibiot (Tokyo); 1992 Oct; 45(10):1609-17. PubMed ID: 1473988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 13-Deoxycarminomycin, a new biosynthetic anthracycline.
    Cassinelli G; Forenza S; Rivola G; Arcamone F; Grein A; Merli S; Casazza AM
    J Nat Prod; 1985; 48(3):435-9. PubMed ID: 3861771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New morpholino anthracyclines, MX, MX2, and MY5.
    Umezawa H; Nakajima S; Kawai H; Komeshima N; Yoshimoto H; Urata T; Odagawa A; Otsuki N; Tatsuta K; Otake N
    J Antibiot (Tokyo); 1987 Jul; 40(7):1058-61. PubMed ID: 3476481
    [No Abstract]   [Full Text] [Related]  

  • 12. New anthracycline antibiotics obtained by microbial glycosidation of beta-isorhodomycinone and alpha 2-rhodomycinone.
    Yoshimoto A; Johdo O; Takatsuki Y; Ishikura T; Sawa T; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1984 Aug; 37(8):935-8. PubMed ID: 6592162
    [No Abstract]   [Full Text] [Related]  

  • 13. Anthracycline antibiotic pharmacology and metabolism.
    Bachur NR
    Cancer Treat Rep; 1979 May; 63(5):817-20. PubMed ID: 455323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The synthesis of epsilon-rhodomycinone- and carminomycin-11-methyl ethers.
    Essery JM; Doyle TW
    J Antibiot (Tokyo); 1979 Mar; 32(3):247-9. PubMed ID: 457585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production and biological activity of marcellomycin, an antitumor anthracycline antibiotic, and taxonomy of the producing organism.
    Bush JA; Bradner WT; Tomita K
    J Antibiot (Tokyo); 1982 Sep; 35(9):1174-83. PubMed ID: 6754675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biologic properties of three anthracyclines as a function of lipophilicity.
    Kessel D
    Biochem Pharmacol; 1979 Oct; 28(19):3028-30. PubMed ID: 518699
    [No Abstract]   [Full Text] [Related]  

  • 17. New antifungal antibiotics, benanomicins A and B from an actinomycete.
    Takeuchi T; Hara T; Naganawa H; Okada M; Hamada M; Umezawa H; Gomi S; Sezaki M; Kondo S
    J Antibiot (Tokyo); 1988 Jun; 41(6):807-11. PubMed ID: 3403377
    [No Abstract]   [Full Text] [Related]  

  • 18. Microbial conversion of anthracycline antibiotics. II. Characterization of the microbial conversion products of auramycinone by Streptomyces coeruleorubidus ATCC 31276.
    Hoshino T; Fujiwara A
    J Antibiot (Tokyo); 1983 Nov; 36(11):1463-7. PubMed ID: 6654755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 167-A, a new antibiotic produced by a mutant of an inactive wild strain of Amycolata autotrophica.
    Malkina ND; Dudnik YV; Lysenkova LN; Lazhko EI; Galatenko OA; Katrukha GS
    J Antibiot (Tokyo); 1994 Mar; 47(3):342-8. PubMed ID: 8175487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The anthracycline antineoplastic drugs.
    Young RC; Ozols RF; Myers CE
    N Engl J Med; 1981 Jul; 305(3):139-53. PubMed ID: 7017406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.